Lv11
30 积分 2021-06-24 加入
OS-030 Efficacy and safety of xalnesiran with and without an immunomodulator in virologically suppressed participants with chronic hepatitis B: end of study results from the phase 2, randomized, controlled, adaptive, open-label platform study (PIRANGA)
3小时前
已完结
Targeting HBV with RNA interference: Paths to cure
3小时前
已完结
Emerging therapies for HBsAg seroclearance: spotlight on novel combination strategies
3小时前
已完结
Sustained Liver HBsAg Loss and Clonal T- and B-Cell Expansion upon Therapeutic DNA Vaccination Require Low HBsAg Levels
3小时前
已完结
The impact of HBsAg reduction via siRNA treatment on natural and vaccine (BRII-179)-induced HBV-specific humoral and cellular immune responses
3小时前
已完结
Analysis of the relationship between <i>Cxcl12, Tweak, Notch1 and Yap1</i> mRNA expression in the molecular mechanisms of liver fibrogenesis
3个月前
已关闭
Analysis of the relationship between <i>Cxcl12, Tweak, Notch1 and Yap1</i> mRNA expression in the molecular mechanisms of liver fibrogenesis
4个月前
已关闭
Reduced circulating levels of sTWEAK are associated with NAFLD and may affect hepatocyte triglyceride accumulation
4个月前
已完结
TWEAK/Fn14 axis is an important player in fibrosis
4个月前
已完结
TWEAK promotes inflammatory response in liver fibrosis
4个月前
已完结
皖公网安备34019202002308
